Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/19740
Title: Bilateral facial nerve palsies secondary to chronic inflammatory demyelinating polyneuropathy following adalimumab treatment
Authors: Yao, Anthony;Chan, Helen;Macdonell, Richard A L;Shuey, Neil;Khong, Jwu Jin
Issue Date: Jan-2018
EDate: 2017-11-22
Citation: Clinical Neurology and Neurosurgery 2018; 164: 64-66
Abstract: PURPOSE: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) presents uncommonly with cranial nerve involvement with ophthalmological implications. METHODS: We report the case of a 37year-old man who developed CIDP which manifested as progressive and relapsing bilateral facial nerve palsy with lagophthalmos and exposure keratopathy, in the setting of treatment of Crohn's disease with the anti-TNF-alpha agent adalimumab. RESULTS: Symptoms gradually improved over the course of several months following withdrawal of adalimumab and treatment with intravenous immunoglobulin (IVIg) and oral prednisolone. CONCLUSION: Bilateral facial nerve involvement occurs uncommonly as a feature of CIDP in its classic form. The prognosis is good for recovery of facial nerve function with discontinuation of anti-TNF-alpha therapy and concurrent use of steroid and intravenous immunoglobulin in this case.
URI: http://ahro.austin.org.au/austinjspui/handle/1/19740
DOI: 10.1016/j.clineuro.2017.11.001
ORCID: 0000-0003-3838-8795
PubMed URL: https://www.ncbi.nlm.nih.gov/pubmed/29179036
Type: Journal Article
Subjects: Adalimumab
Anti-TNF-alpha
Chronic inflammatory demyelinating polyneuropathy
Type of Clinical Study or Trial: Case Series and Case Reports
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.